Investing Profile

Mark Velleca

InvestorVC
Venture Partner at Hatteras Venture Partners
hatterasvp.comDurham, North Carolina
Photo of Mark Velleca, Venture Partner at Hatteras Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Yale University Network
289 CONNECTIONS
Yale University Network
289 CONNECTIONS
Washington University in St. Louis Network
70 CONNECTIONS
Washington University in St. Louis Network
70 CONNECTIONS
Yale University Network
37 CONNECTIONS
cb
$100K - $5.0M
$1.5M
$94M
Research Assistant Yale UniversityPresent
Resident, Chief Resident, Fellow, Attending Physician Yale New Haven HospitalPresent
Associate Research Scientist Yale University School of MedicinePresent
Assistant Clinical Professor (adjunct) Yale University School of MedicinePresent
Senior Advisor Gilead SciencesPresent
Chief Policy and Advocacy Officer The Leukemia & Lymphoma SocietyPresent
Board Director Black Diamond TherapeuticsPresent
Board Chair IMMvention Therapeutix, Inc.Present
Board Chair Black Diamond TherapeuticsPresent
Board Director CREATE MedicinesPresent
Board Chair iOncturaPresent
Founder and SVP CGI Pharmaceuticals, Inc.Present
CEO, Board Director G1 Therapeutics, Inc.Present
Advisor, CEO, Board Director StrideBio, IncPresent
Venture Partner Hatteras Venture PartnersPresent
CEO Black Diamond TherapeuticsPresent
Yale University B.S., Cum Laude Biology
Yale University B.S. Cum Laude, Biology
Washington University in St. Louis M.D., Ph.D. Neuroscience
Washington University in St. Louis M.D. Ph.D., Neuroscience